Gender | Age
Item
women who are 18 years of age or older
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender | Excision elective Early-Stage Breast Carcinoma
Item
women electing to undergo excision surgery for early stage breast cancer
boolean
C0079399 (UMLS CUI [1])
C0728940 (UMLS CUI [2,1])
C0439608 (UMLS CUI [2,2])
C2986665 (UMLS CUI [2,3])
Enrollment Operative Surgical Procedures Definitive
Item
a minimum of 2 weeks from enrollment to definitive surgery
boolean
C1516879 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C0443196 (UMLS CUI [1,3])
Core needle biopsy Breast Carcinoma
Item
underwent core needle biopsy for breast cancer diagnosis
boolean
C1318309 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
Secondary malignant neoplasm of female breast Evidence Lacking
Item
no clinical evidence of metastatic breast cancer
boolean
C0346993 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Organ function | Bone Marrow function
Item
participants must have normal organ and marrow function
boolean
C0678852 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods
Item
women of child-bearing potential must agree to use adequate contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Informed Consent
Item
ability to understand and the willingness to sign a written informed consent document
boolean
C0021430 (UMLS CUI [1])
Chemotherapy | Therapeutic radiology procedure
Item
concurrent chemotherapy or radiation therapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Selective Estrogen Receptor Modulators | Aromatase Inhibitors
Item
use of selective estrogen receptor modifiers or aromatase inhibitors within the past 3 months or concurrently
boolean
C0732611 (UMLS CUI [1])
C0593802 (UMLS CUI [2])
Cancer Other | Exception Skin carcinoma | Exception Organ removal Therapeutic procedure only
Item
history of other malignancies within the past 5 years excluding non-melanoma skin cancer and cancers confined to organs with removal as only treatment
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C1408858 (UMLS CUI [3,2])
C0087111 (UMLS CUI [3,3])
C0205171 (UMLS CUI [3,4])
Study Subject Participation Status | Intervention
Item
participated in another clinical intervention trial within the past 3 months
boolean
C2348568 (UMLS CUI [1])
C0184661 (UMLS CUI [2])
Comorbidity Uncontrolled | Communicable Diseases | Symptomatic congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Mental disorders Protocol Compliance Limited | Social situation Protocol Compliance Limited
Item
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0742758 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0003811 (UMLS CUI [5])
C0004936 (UMLS CUI [6,1])
C0525058 (UMLS CUI [6,2])
C0439801 (UMLS CUI [6,3])
C0748872 (UMLS CUI [7,1])
C0525058 (UMLS CUI [7,2])
C0439801 (UMLS CUI [7,3])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Dietary Supplements | d-limonene | Other Coding
Item
use of dietary supplement that contains large amounts of d-limonene (such as heartburn free with roh10 and coq with d-limonene) within the past 3 months
boolean
C0242295 (UMLS CUI [1])
C0950252 (UMLS CUI [2])
C3846158 (UMLS CUI [3])